Novartis to buy biotechnology firm for $9.7 billion
                                        
                                            
                                                25 Nov 2019
                                            
                                        
                                        
                                            Novartis AG is buying US biotechnology company The Medicines Co for about $9.7 billion, the Swiss drugmaker said, as it seeks to expand its portfolio of medicines against cardiovascular disease....